A reliable PEDV result starts before a sample reaches the PCR instrument. Sample quality, RNA recovery, and assay design all shape what the final signal can tell you. Here is how these pieces fit together, with a practical look at sampling, detection methods, and a one-step RT-qPCR workflow.

Why early detection matters

Porcine epidemic diarrhea (PED) is a highly contagious intestinal disease caused by porcine epidemic diarrhea virus (PEDV), an enveloped, single-stranded RNA virus. It can affect pigs of all ages, but newborn piglets are especially vulnerable. Typical signs include vomiting, watery diarrhea, dehydration, and rapid weight loss; severe outbreaks can cause very high mortality in young piglets.

PEDV spreads mainly through the fecal–oral route. Contaminated animals, materials, and farm environments can help move the virus between groups and sites. Prompt detection supports a faster response, while poor sampling can leave an otherwise sensitive assay with little useful material to detect.

Start with a representative sample

Fresh samples from pigs in the early stage of illness are generally the most informative. The collection window described here is the first 1–3 days after signs appear, when viral shedding may be high. Prioritize animals with typical signs rather than animals that have already recovered.

Fresh feces are a common starting point. Collect approximately 5–10 g with a sterile swab or sampling spoon, keeping the sample away from soil, feed, and other contaminants. Place it in a sterile tube and label the animal, date, and collection site.

For postmortem sampling, the example workflow uses duodenum, jejunum, or ileum tissue, approximately 2–3 g, collected aseptically after removing intestinal contents. Fresh vomit, approximately 5 mL, is another sample type described in the workflow and should be collected in a sterile, sealed container.

Keep samples cold and traceable

Refrigerate samples at 4°C for short-term holding of up to 24 hours. For longer storage, the example workflow specifies −80°C. Maintain a cold chain during transport, avoid repeated freezing and thawing, and include the sampling location, animal group, and clinical observations with each submission. Follow the receiving laboratory’s requirements for the selected sample type.

Choose the method that answers your question

Antibody testing, molecular testing, and virus isolation measure different things. Antibody assays can help assess prior exposure or immune responses, while molecular assays look for viral RNA. Virus isolation is useful when live virus is needed for further characterization, but it takes more time and specialist facilities.

Method

What it measures

Where it fits

Serology

PEDV-specific antibodies; commonly ELISA or IFA

Retrospective assessment and immune-response evaluation. Antibody development can take about 7–10 days, limiting early detection.

Molecular testing

Viral RNA; RT-PCR or RT-qPCR

Early detection and screening. Sensitive and specific when validated, but dependent on extraction quality, controls, and contamination management.

Virus isolation

Recoverable, infectious virus

Virus characterization and vaccine research. Typically takes 3–7 days and is less suited to rapid screening.

Build the workflow around RNA quality

The extraction-based workflow has two main parts: recover viral RNA, then run reverse transcription and real-time PCR in a single tube. MolPure™ Magnetic Universal Viral DNA/RNA Kit (18521ES) provides a magnetic bead extraction option, while Hifair™ Universal Advanced Multiplex One Step RT-qPCR Mix (UDG Plus, 16930ES) supplies the amplification reagents.

In the extraction example, 200 µL of serum or clarified tissue homogenate is combined with lysis-binding solution, Proteinase K, and magnetic beads. Mixing at 50°C for 5–7 minutes releases nucleic acids and supports binding to the beads. Magnetic separation is followed by sequential washes with Wash A and Wash B to remove proteins, inhibitors, and other carryover.

The washed beads are eluted with nuclease-free water or the supplied elution buffer at 60°C for 5 minutes, and the RNA-containing supernatant is collected after magnetic separation. Sample preparation must be appropriate for the matrix: a serum or tissue-homogenate example does not automatically validate extraction from every fecal sample.

Protect RNA throughout the process

Use RNase-free consumables, fresh gloves, and a clean workspace. Keep RNA cold, minimize handling and freeze–thaw cycles, and prepare amplification reactions on ice. A dUTP/UDG system helps reduce carryover from compatible PCR products, but clean handling and suitable controls remain essential.

A closer look at the one-step RT-qPCR reaction

The 25 µL example below uses 16930ES. PEDV-specific primers, probes, and template RNA must be supplied separately; the master mix is a general amplification reagent rather than a complete PEDV-specific assay.

Component

Volume in 25 µL

Final concentration

5× Hifair™ MP Buffer (16930-A)

5 µL

1×

Hifair™ Enzyme Mix (16930-B)

1 µL

—

GC-Enhancer (16930-C)

0.5 µL

—

Each primer (10 µM)

0.4 µL each

0.16 µM each

Each probe (10 µM)

0.2 µL each

0.08 µM each

Template RNA

1–5 µL

—

RNase-free water

To 25 µL

—

Primer and probe volumes are listed per individual oligonucleotide. Adjust RNase-free water to a total reaction volume of 25 µL after all components have been added.

Match cycling conditions to the assay and instrument

The example workflow offers standard and fast cycling options. Both combine reverse transcription with amplification; fast cycling requires a compatible instrument and confirmation that the assay performs as intended.

Standard cycling

Stage

Temperature

Time

Cycles

Reverse transcription

50°C

15 min

1

Initial denaturation

95°C

5 min

1

Denaturation

95°C

15 sec

45

Annealing and extension

60°C

30 sec

Same 45 cycles

Reverse transcription may be optimized at 50–55°C for 10–15 minutes. Set annealing temperature according to primer design and allow enough time for fluorescence acquisition on the selected instrument.

Fast cycling

Stage

Temperature

Time

Cycles

Reverse transcription

50°C

2 min

1

Initial denaturation

95°C

30 sec

1

Denaturation

95°C

5 sec

40

Annealing and extension

60°C

15 sec

Same 40 cycles

Confirm fast-ramp compatibility before using the shortened program. Acquire fluorescence during the annealing and extension step according to the assay and instrument settings.

Read the result in the context of the controls

Include a positive control, an appropriate negative sample control, and a no-template control. This example uses Ct ≤35 with a typical amplification curve as its positive criterion; this is an example threshold that must be validated for the specific assay. A negative control signal or a failed positive control makes the run unsuitable for interpretation. Probe-based RT-qPCR is assessed using amplification curves and validated Ct rules, rather than a melt-curve criterion.

Figure. High Detection Rate: Extracted nucleic acids from vaccine samples were tested with Yeasrn RT-qPCR reagent on Tianlong qPCR instruments for three swine diarrhea targets at limit-of-sensitivity concentrations, achieving 100% detection across all samples in the sensitivity range.

Figure. High Detection Rate: Extracted nucleic acids from vaccine samples were tested with Yeasrn RT-qPCR reagent on Tianlong qPCR instruments for three swine diarrhea targets at limit-of-sensitivity concentrations, achieving 100% detection across all samples in the sensitivity range.

Figure. Sensitivity Test: 20 replicates of 0.5 copies/μL PEDV plasmid reference template showed 100% detection rate with good peak morphology. Yeasrn RT-qPCR reagent achieves sensitivity of 5 copies/test or superior.

Figure. Sensitivity Test: 20 replicates of 0.5 copies/μL PEDV plasmid reference template showed 100% detection rate with good peak morphology. Yeasrn RT-qPCR reagent achieves sensitivity of 5 copies/test or superior.

Why RT-qPCR fits rapid PEDV screening

RT-qPCR can detect low levels of viral RNA before antibody testing becomes informative. PEDV-specific primers and probes provide target selectivity, while real-time fluorescence supports detection and, with suitable standards, quantitative analysis. Specificity, cross-reactivity, and the detection limit depend on the complete assay and need confirmation for the intended sample types.

An extraction-plus-amplification workflow can be completed in approximately 3–4 hours, with batch processing supporting higher sample volumes. Fast master mixes can further shorten the amplification stage. Standardized reactions and automated extraction help laboratories scale their workflow, while appropriate assay validation determines whether results can support the intended testing application.

YEASEN reagents and extraction platforms

Match the reagent format to the sample, turnaround time, and throughput you need. The following products cover extraction, one-step RT-qPCR, and automated sample processing.

Cat. No.

Product

Workflow fit

18521ES

Hieff™ Magnetic Universal Viral DNA/RNA Kit

Magnetic bead purification; manual or automated extraction.

16930ES

Hifair™ Universal Advanced Multiplex One Step RT-qPCR Mix (UDG Plus)

Broad compatibility and inhibitor tolerance; dUTP/UDG; fast cycling under 35 min.

16983ES

Hifair™ Multiplex Superfast One Step RT-qPCR Probe Mix (UDG Plus)

Fast cycling with a dUTP/UDG carryover-control system.

16921ES

Hifair™ Advanced One Step RT-qPCR Probe Mix (UDG Plus)

5× formulation with a dUTP/UDG carryover-control system.

13650ES

Hifair™ V C58P2 Multiplex One Step RT-qPCR Probe Kit (UDG Plus)

Multiplex probe-based detection; supports a 40-min fast program.

16913ES

Hifair™ Superpro Fast One Step RT-qPCR Master Mix (UDG Plus)

Complete premix; supports fast cycling and primer/probe premixing.

80511ES

AP-48 Automated Nucleic Acid Extractor

48 samples per run for medium-throughput extraction.

80510ES

AP-96 Automated Nucleic Acid Extractor

96 samples per run for higher-throughput extraction.

Performance specifications refer to the individual reagent or platform and do not establish PEDV-specific assay performance. These reagents are supplied for research use; PEDV-specific assay development requires appropriate primers, probes, controls, and validation.

From a fresh sample to a clear amplification signal, reliable PEDV testing depends on the whole workflow. Start with representative material, protect RNA quality, and choose reagents and instruments that work together under validated conditions.

Anfrage